Benefit/risk ratio of new drugs: for whom? Discussion paper.
Palminteri
R
R
Drug Surveillance Unit (Clinical Research), Laboratoire d'Etudes et de Recherches Synthelabo, Paris, France.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D012307:Risk Factors